ADRC, Inc. Presents $3,000 Research Grant to Winthrop-University Hospi

Money Will Fund Study on How New Formulation and Dosing of Anti-Dementia Medication Will Impact Alzheimer’s Patients
Spread the Word
Listed Under

Alzheimer S Disease


June 25, 2014 - PRLog -- Who:          Mary Ann Malack-Ragona, Executive Director/Chief Executive Officer, Alzheimer’s Disease Resource Center, Inc.

         Irving H. Gomolin, MD, Chief, Division of Geriatric Medicine, Winthrop-University Hospital

         Representatives from Winthrop-University Hospital

What:          Mary Ann Malack-Ragona, Executive Director/CEO, Alzheimer’s Disease Resource Center, Inc., will present a check in the amount of $3,000 to Dr. Irving H. Gomolin, Chief, Division of Geriatric Medicine, Winthrop-University Hospital. The grant will assist Dr. Gomolin to study how the removal of standard Namenda tablets from the marketplace and substitution with an extended release formulation will impact the blood levels of Alzheimer’s patients.

Namenda — also known as memantine — is an oral medication used to treat moderate to severe dementia related to Alzheimer’s Disease. While it does not cure AD, it may improve memory, awareness and the ability to perform daily functions. Namenda works by blocking the action of glutamate, a natural substance in the brain that is believed to be linked to symptoms of AD.

The standard tablet formulation of the drug is being removed from the marketplace in August 2014 without any available generic versions in the U.S. because patent rights to the drug do not expire until 2015. Instead, Alzheimer’s patients can be switched to an extended release formulation of memantine.

In his study, Dr. Gomolin will measure whether the switch from the standard tablets to the extended release formulation will result in important changes in blood concentrations of this medication among patients with Alzheimer’s dementia.

When:          Thursday, June 26, 2014
         3:30 p.m.

Where:          Office of Dr. Irving H. Gomolin

         222 Station Plaza, Suite 518

         Mineola, NY

     LIE to Exit 37 toward Willis Ave./Mineola/Roslyn. Merge onto Powerhouse Rd. Turn left onto Mineola Ave. Continue onto Willis Ave., then turn right onto Hillside Avenue. Make a left onto Mineola Blvd. After a mile, turn right onto 2nd St. Take the first left onto Mineola Blvd. After that, take the first right onto Front St. Dr. Gomolin’s office will be on the right-hand side.

Photo Ops:      Ms. Malack-Ragona presenting the check to Dr. Gomolin. Ms. Malack-Ragona and Dr. Gomolin joined by Winthrop-University Hospital representatives. Dr. Gomolin explaining what his research entails.


Alzheimer’s Disease Resource Center, Inc. ( — which is headquartered in Bay Shore and has a satellite office in Southampton — is the only local Alzheimer’s Disease advocacy and educational facility whose mission is to provide hands-on support and services to families on Long Island and the New York metropolitan area. ADRC works with family members, health care professionals and researchers to ensure quality health care and support to those impacted by Alzheimer’s Disease through care and consultation, information and referral, training, support groups, and caregiver safety products.

The Public Relations and Marketing Group
Source:Alzheimer's Disease Resource Center, Inc.
Email:*** Email Verified
Tags:Alzheimer S Disease, Dementia, Grants
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Trending News
Top Daily News
Top Weekly News

Like PRLog?
Click to Share